Isabel Kim

Isabel Kim

Auto-generated profile, based on publicly available information

Isabel Kim

Division of Cardiovascular Medicine, Department of Medicine, Stanford University School of Medicine , CVRC Falk, 300 Pasteur Drive, Stanford, CA 94305

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2022 in Canadian Journal of Cardiology
Verified
Journal Article
Closed access
IKIsabel Kim
Isabel Kim
TFThalia S. Field
Thalia S. Field
DWDarryl Wan
Darryl Wan
KHKarin Humphries
Karin Humphries
TSTara Sedlak
Tara Sedlak

1 February 2016 in Systematic Reviews
Verified
Journal Article
Open access
PDF file
HSHarsha Shanthanna
Harsha Shanthanna
JBJason W Busse
Jason W Busse
LTLehana Thabane
Lehana Thabane
JPJames Paul
James Paul
RCRachel Couban
Rachel Couban
PHPrathiba Harsha
Prathiba Harsha
Steroids are often combined with local anesthetic (LA) and injected to reduce pain associated with various chronic non-cancer pain (CNCP) complaints. The biological rationale behind injection of a steroid solution is unclear, and it is uncertain whether the addition of steroids offers any additional benefits over injection of LA alone. We propose to conduct a systematic review and meta-analysis to summarize the evidence for using steroids and LA vs. LA alone in the treatment of CNCP. An experienced librarian will perform a comprehensive search of EMBASE, MEDLINE, and the Cochrane Central Registry of Controlled Trials (CENTRAL) databases with search terms for clinical indications, LA, and steroid agents. We will review bibliographies of all relevant published reviews in the last 5 years for additional studies. Eligible trials will be published in English and randomly allocate patients with CNCP to treatment with steroid and LA injection therapy or injection with LA alone. We will use the guidelines published by the Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT) to inform the outcomes that we collect and present. Teams of reviewers will independently and in duplicate assess trial eligibility, abstract data, and assess risk of bias among eligible trials. We will prioritize intention to treat analysis and, when possible, pool outcomes across trials using random effects models. We will report our findings as risk differences, weighted mean differences, or standardized mean differences for individual outcomes. Further, to ensure interpretability of our results, we will present risk differences and measures of relative effect for pain reduction based on anchor-based minimally important clinical differences. We will conduct a priori defined subgroup analyses and use the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system to evaluate the certainty of the evidence on an outcome-by-outcome basis. Our review will evaluate both the effectiveness and the adverse events associated with steroid plus LA vs. LA alone for CNCP, evaluate the quality of the evidence using the GRADE approach, and prioritize patient-important outcomes guided by IMMPACT recommendations. Our results will facilitate evidence-based management of patients with chronic non-cancer pain and identify key areas for future research. PROSPERO CRD42015020614

18 May 2024 in Journal of the Society for Cardiovascular Angiography & Interventions
Verified
Journal Article
Open access
LDLuke P. Dawson
Luke P. Dawson
IKIsabel Kim
Isabel Kim
CHChristiane Haeffele
Christiane Haeffele
RSRahul Sharma
Rahul Sharma
We present the case of an 82-year-old woman with persistent fatigue, exertional dyspnea, and dizziness related to a paravalvular leak following a self-expanding transcatheter aortic valve replacement. Successful closure was performed using a steerable sheath to negotiate a vascular plug closure device through the self-expanding valve structure.

1 November 2024 in European Heart Journal - Case Reports
Verified
Journal Article
Open access
PDF file
IKIsabel Kim
Isabel Kim
XLXi E Li
Xi E Li
PLPascal T Lauzier
Pascal T Lauzier
RSRahul P Sharma
Rahul P Sharma
CHChristiane Haeffele
Christiane Haeffele
Background: An 85-year-old woman was referred for mitral valve transcatheter edge-to-edge repair (TEER) following multiple heart failure hospitalizations related to her severe functional mitral regurgitation. In addition to previous transcatheter aortic valve replacement for aortic stenosis, her past medical history was significant for chronic steroid use related to microscopic polyangiitis leading to renal transplantation. Case summary: Her procedure was complicated by an interatrial septum dissection with associated haemopericardium originating from the transseptal puncture site. To our knowledge, our case demonstrates the first use of an Amplatzer occluder device to manage this complication by preventing ongoing flow into the pericardial space. This complication occurred in the setting of a single, successful transseptal puncture in the typical location for a mitral valve TEER procedure, raising the consideration that chronic steroid use may be an underappreciated risk factor for iatrogenic interatrial septal damage. Discussion: Transoesophageal echocardiography is integral to identifying and risk stratifying this complication, and imagers should have a low threshold to screen for it, particularly in the setting of haemodynamic compromise. The decision to deploy a closure device should be made on a case-by-case basis considering the risks and benefits of doing so compared with conservative management.